Can Thykamine change the future of MASH treatment? Devonian Health Group says yes!

Devonian Health Group Inc. (TSXV: GSD; OTCQB: DVHGF), a clinical-stage pharmaceutical company, has announced promising preclinical results for its proprietary drug candidate, Thykamine, in MASH ... Read More